RecruitingInternal Hemorrhoid
Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
Eligible age
18–90 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Sponsor: Mayo Clinic
You may qualify if…
- ✓ Grade II or III hemorrhoidal disease as determined by a board-certified colorectal surgeon.
- ✓ Persistent or recurrent symptoms following hygiene and dietary measures or medication.
- ✓ Bleeding predominant ± pain symptoms.
- ✓ Undergoing planned rectal artery embolization (RAE) per standard clinical care.
- ✓ Male or female with age greater than 18 years, with the capacity and willingness to provide a written informed consent.
- ✓ Negative pregnancy test (if applicable).
You may not qualify if…
- ✕ Prior hemorrhoid surgery.
- ✕ Grade IV hemorrhoidal disease.
- ✕ Acute hemorrhoid complications.
- ✕ Chronic anal or perianal fissures.
- ✕ History of colorectal surgery or pelvic radiation.
- ✕ Inflammatory bowel disease.
- ✕ Portal hypertension or mesenteric venous congestion/occlusion.
- ✕ Inferior mesenteric artery (IMA) or internal iliac artery (IIA) stenosis or occlusion.
Where it's recruiting
Minnesota
Rochester
Source: ClinicalTrials.gov · NCT06106269 · last updated 2026-06-17